Susquehanna Trust & Investment’s GSK GSK Stock Holding History

Susquehanna Trust & Investment’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2015 Q2	$488K	Sell	9,382 -569	-6%	-$32K	0.11%	80
2015 Q1	$574K	Sell	9,951 -1,494	-13%	-$85.7K	0.12%	74
2014 Q4	$612K	Sell	11,445 -105,780	-90%	-$5.92M	0.12%	73
2014 Q3	$6.74M	Sell	117,225 -655	-0.6%	-$40.2K	1.46%	35
2014 Q2	$7.88M	Sell	117,880 -1,542	-1%	-$104K	1.67%	27
2014 Q1	$7.98M	Buy	119,422 +468	+0.4%	+$31.6K	1.77%	21
2013 Q4	$7.94M	Sell	118,954 -14,650	-11%	-$950K	1.71%	25
2013 Q3	$8.38M	Buy	133,604 +414	+0.3%	+$26.6K	1.83%	23
2013 Q2	$8.32M	Buy	+133,190	New	+$8.45M	1.95%	21

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Susquehanna Trust & Investment's GSK Position: Q2 2015 in Review

Susquehanna Trust & Investment reduced its GSK (GSK) stake by 5.7% in Q2 2015, selling an estimated $32K and leaving 9,382 shares worth $488K. The position accounts for 0.11% of the portfolio, ranked #80.

Susquehanna Trust & Investment first reported a position in GSK in Q2 2013 and has held it in 9 quarters since. The position peaked at $8.38M in Q3 2013. 719 funds tracked by Wall St. Rank hold GSK as of Q2 2015.

Susquehanna Trust & Investment held 9,382 shares of GSK worth $488K as of Q2 2015.
Susquehanna Trust & Investment sold 569 GSK shares in Q2 2015, an estimated $32K.
GSK made up 0.11% of Susquehanna Trust & Investment's portfolio in Q2 2015, its #80 holding.
Susquehanna Trust & Investment first reported a position in GSK in Q2 2013 and has held it in 9 quarters since.
Susquehanna Trust & Investment's GSK position peaked at $8.38M in Q3 2013.
719 funds tracked by Wall St. Rank held GSK as of Q2 2015.

Based on Susquehanna Trust & Investment's 13F filing for Q2 2015, filed 24 Jul 2015.